Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Ambassadors of change, NGO
Street 1: Kenyatta Avenue
Street 2:
City: Nakuru
Province: Rift Valley
Post Code: 20100
Country: Kenya
Phone: +254727611175
Email: paulmoseskirobia@yahoo.com
Web Site:

Focal Point Contact Information

Salutation: MR
First Name: PAUL MOSES
Last Name: NDEGWA
Title: CEO
Email: paulmoseskirobia@yahoo.com
Phone: +254727611175

Alternate Focal Point Contact Information

Salutation: Mrs
First Name: Patricia
Last Name: Kieya
Title:  
Email: patriciakieya@gmail.com
Phone:  

General Information

Board Constituency: Developing Country NGO
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Community-Based Organization (CBO)
Is your organization legally registered in your country: Yes
Organization Reach: National
Organization Description:
PROMOTING HEALTH RIGHTS, ADVOCACY FOR STRENGTHENED HEALTH SYSTEMS AND HEALTH WORKFORCE, ACCESS TO MEDICINES.REDUCTION, ELIMINATION OF COMMUNICABLE AND NON-COMMUNICABLE DISEASES,RESPONSE TO IMPACT OF RAPID URBANIZATION ON HEALTH WHILE DEVELOPING EFFECTIVE STRATEGIES TO ADDRESS CRITICAL ISSUES POSING CHALLENGES TO PUBLIC HEALTH E.G OVERCROWDING, SLUMS FORMATIONS, INSECURITY, POOR SANITATION, TB/HIV CO- INFECTIONS, LACK OF ACCESS TO HEALTH CARE SERVICES, AND INCREASED POVERTY.
TB REMAINS NO ONE KILLER DISEASE IN THE GLOBAL SOUTH COMPOUNDED BY MDR-TB, HIGH HIV PREVALENCE , AND WEAK HEALTH PROGRAMS AND SYSTEMS HENCE THE URGENT NEED TO ADVOCATE FOR INCREASED FUNDING FOR EFFECTIVE RESPONSE TO THE DISEASE AT GRASSROOTS LEVELS THROUGH OUTREACHES,MODERN COMMUNICATION TECHNOLOGIES AND MEDIA STRATEGY TO DISSEMINATE ACCURATE INFORMATION ON PREVENTIVE METHODS, IMPROVED DIAGNOSIS AND TREATMENT AND INCREASED CAPACITY AMONG HEALTH PROVIDERS ON DIAGNOSTICS AND TREATMENT. ADVOCACY FOR ALTERNATIVE TB DRUGS TO BE USED FOR LESSER PERIOD BY TB PATIENTS.
CURRENTLY, ENGAGED IN DEFAULTER TRACING,COMMUNITY MOBILIZATION TO TEST TB, SIGNS AND OF SYMPTOMS FOR EARLY INITIATION TO TREATMENT
 
Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 26 - 50
 
What is your organization's annual budget (USD) dedicated to TB? $5,001-$10,000
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
SURVEILLANCE , MONITORING TRENDS,PLANNING AND PROGRAMMING AND ADVOCACY
 

Geographical Reach

Which country is your headquarters located in: Kenya
Which WHO region is the main focus of your work: African
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Kenya

Specializations

Advocacy
Research and Development

Specializations in Countries

Advocacy Kenya

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
ADVOCACY FOR TB TREATMENT BEYOND DOTS

Drug-Resistant TB:
PROMOTING COMMUNITY KNOWLEDGE ON TB SYMPTOMS, NEED FOR EARLY TREATMENT AND ADHERENCE TO MEDICATION TO REDUCE CASES OF Drug-Resistant TB

TB-HIV:
Reduction of stigma associated with the two diseases as barrier to testing and treatment including advocacy for integrated health care delivery in both public ,private sectors and workplaces

Laboratory Strengthening:
Ensuring essential equipments are available, accessible both in rural and urban settings to diagnose TB cases and detect MDR-TB including proper training among clinicians and data collection , storage and analysis for improved programming and treatment

New Diagnostics:
Diagnostics on TB drug resistance among patients particularly HIV Positives and new diagnostics that goes beyond x-rays and sputum tests.

New TB Drugs:
combination of drugs to reduce fatigue among patients and enhance adherence.

Research:
Assessment of impact of integration of TB/HIV prevention,treatment and developing mechanisms aimed at addressing the gaps.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: November 16, 2011
Last updated: November 26, 2013